154 related articles for article (PubMed ID: 33034328)
1. PLGA/chitosan-heparin composite microparticles prepared with microfluidics for the construction of hMSC aggregates.
Ge M; Sheng Y; Qi S; Cao L; Zhang Y; Yang J
J Mater Chem B; 2020 Nov; 8(43):9921-9932. PubMed ID: 33034328
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
[TBL] [Abstract][Full Text] [Related]
3. Construction of multicellular aggregate by E-cadherin coated microparticles enhancing the hepatic specific differentiation of mesenchymal stem cells.
Cao L; Zhang Y; Qian M; Wang X; Shuai Q; Gao C; Lang R; Yang J
Acta Biomater; 2019 Sep; 95():382-394. PubMed ID: 30660779
[TBL] [Abstract][Full Text] [Related]
4. Duo Cadherin-Functionalized Microparticles Synergistically Induce Chondrogenesis and Cartilage Repair of Stem Cell Aggregates.
Wang X; Xu X; Zhang Y; An X; Zhang X; Chen G; Jiang Q; Yang J
Adv Healthc Mater; 2022 Jul; 11(13):e2200246. PubMed ID: 35485302
[TBL] [Abstract][Full Text] [Related]
5. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
6. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
7. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
8. Delayed release of chemokine CCL25 with bioresorbable microparticles for mobilization of human mesenchymal stem cells.
Fröhlich K; Hartzke D; Schmidt F; Eucker J; Gurlo A; Sittinger M; Ringe J
Acta Biomater; 2018 Mar; 69():290-300. PubMed ID: 29408710
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles - development, characterisation, and
Hameed A; Gallagher LB; Dolan E; O'Sullivan J; Ruiz-Hernandez E; Duffy GP; Kelly H
J Microencapsul; 2019 May; 36(3):267-277. PubMed ID: 31195912
[No Abstract] [Full Text] [Related]
10. Optimising poly(lactic-co-glycolic acid) microparticle fabrication using a Taguchi orthogonal array design-of-experiment approach.
Mensah RA; Kirton SB; Cook MT; Styliari ID; Hutter V; Chau DYS
PLoS One; 2019; 14(9):e0222858. PubMed ID: 31557205
[TBL] [Abstract][Full Text] [Related]
11. Hierarchically porous composite microparticles from microfluidics for controllable drug delivery.
Zhao X; Liu Y; Yu Y; Huang Q; Ji W; Li J; Zhao Y
Nanoscale; 2018 Jul; 10(26):12595-12604. PubMed ID: 29938277
[TBL] [Abstract][Full Text] [Related]
12. Chitosan/carboxymethylcellulose-stabilized poly(lactide-co-glycolide) particles as bio-based drug delivery carriers.
Inphonlek S; Sunintaboon P; Léonard M; Durand A
Carbohydr Polym; 2020 Aug; 242():116417. PubMed ID: 32564826
[TBL] [Abstract][Full Text] [Related]
13. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Delivery of VEGF-A
Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
[TBL] [Abstract][Full Text] [Related]
15. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions.
Tamani F; Bassand C; Hamoudi MC; Danede F; Willart JF; Siepmann F; Siepmann J
Int J Pharm; 2019 Dec; 572():118819. PubMed ID: 31726196
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Biological Functions of Human Mesenchymal Stem-Cell Aggregates Incorporating E-Cadherin-Modified PLGA Microparticles.
Zhang Y; Mao H; Gao C; Li S; Shuai Q; Xu J; Xu K; Cao L; Lang R; Gu Z; Akaike T; Yang J
Adv Healthc Mater; 2016 Aug; 5(15):1949-59. PubMed ID: 27245478
[TBL] [Abstract][Full Text] [Related]
18. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
Mylonaki I; Allémann E; Delie F; Jordan O
J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
[TBL] [Abstract][Full Text] [Related]
19. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
20. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
